A double-labeling immunohistochemical study of tau exon 10 in Alzheimer’s disease, progressive supranuclear palsy and Pick’s disease

Abstract Neurofibrillary tangles (NFT), one of the histopathological hallmarks of Alzheimer’s disease (AD) and progressive supranuclear palsy (PSP), and Pick bodies in Pick’s disease (PiD) are composed of microtubule-associated protein tau, which is the product of alternative splicing of a gene on chromosome 17. Alternative expression of exon 10 leads to formation of three- or four-repeat tau isoforms. To study the differential expression of exon 10, we performed double-labeling immunohistochemistry of the hippocampal formation in nine AD, four PSP and three PiD cases. Cryostat sections were processed with and without formic acid (FA) treatment, and double-stained with anti-tau (Alz-50 or PHF-1) or anti-amyloid P component antibodies and one of two specific anti-exon 10 antibodies (E-10). The effect of proteinase-K treatment was also evaluated. The results suggest the following. First, in AD, E-10 immunoreactivity is present in most intracellular NFT, but not in most dystrophic neurites and neuropil threads, suggesting differential expression of tau isoforms in specific cellular domains. Second, in AD, E-10 immunoreactivity is lost or blocked in most extracellular NFT, possibly due to proteolysis. Third, in PSP, E-10 immunoreactivity is hidden or blocked in NFT and tau-positive glial inclusions, but FA treatment exposes the epitope consistent with the hypothesis that PSP inclusions contain four-repeat tau. Fourth, E-10 immunoreactivity is present in dentate fascia NFT in AD and PSP, but not in Pick bodies in the dentate fascia or other areas. The results suggest that expression of exon 10 in tau is specific for cellular domains in a disease-specific manner.

[1]  D. Hanger,et al.  Tau in Alzheimer neurofibrillary tangles. N- and C-terminal regions are differentially associated with paired helical filaments and the location of a putative abnormal phosphorylation site. , 1991, The Biochemical journal.

[2]  M. Roth,et al.  Immunohistochemical Staging of Neurofibrillary Degeneration in Alzheimer's Disease , 1994, Journal of neuropathology and experimental neurology.

[3]  P. Mcgeer,et al.  Dystrophic neurites are associated with early stage extracellular neurofibrillary tangles in the parkinsonism-dementia complex of Guam , 1997, Acta Neuropathologica.

[4]  A. Delacourte,et al.  Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases , 1997, FEBS letters.

[5]  D. Dickson,et al.  Neurodegenerative diseases with cytoskeletal pathology: A biochemical classification , 1997, Annals of neurology.

[6]  G. Perry,et al.  Ultrastructural localization of beta-amyloid, tau, and ubiquitin epitopes in extracellular neurofibrillary tangles. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Tabaton,et al.  Neuropil threads of Alzheimer's disease show a marked alteration of the normal cytoskeleton , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[8]  M. Kirschner,et al.  Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. , 1977, Journal of molecular biology.

[9]  M. Goedert,et al.  Localization of the Alz-50 epitope in recombinant human microtubule-associated protein tau , 1991, Neuroscience Letters.

[10]  G. Drewes,et al.  Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro , 1992, The Journal of cell biology.

[11]  M. Kirschner,et al.  A protein factor essential for microtubule assembly. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[12]  C. W. Scott,et al.  Immunological characterization of the region of tau protein that is bound to Alzheimer paired helical filaments , 1992, Neurobiology of Aging.

[13]  A. Delacourte,et al.  Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their τ isoform distribution and phosphorylation , 1998, Annals of neurology.

[14]  J. Trojanowski,et al.  Intraneuronal and extracellular neurofibrillary tangles exhibit mutually exclusive cytoskeletal antigens , 1988, Annals of neurology.

[15]  S. Yen,et al.  Differential expression of exons 10 and 11 in normal tau and tau associated with paired helical filaments , 1995, Journal of neuroscience research.

[16]  G. Drewes,et al.  Microtubule‐associated Protein Tau, Paired Helical Filaments, and Phosphorylation a , 1993, Annals of the New York Academy of Sciences.

[17]  A. Klug,et al.  Molecular analysis of neurofibrillary degeneration in Alzheimer's disease. An immunohistochemical study. , 1990, The American journal of pathology.

[18]  Ronald C. Petersen,et al.  Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.

[19]  A. Delacourte,et al.  Neurofibrillary Degeneration in Progressive Supranuclear Palsy and Corticobasal Degeneration , 1999, Journal of neurochemistry.

[20]  M. Goedert,et al.  Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. , 1990, The EMBO journal.

[21]  D. Dickson.  Pick's Disease: A Modern Approach , 1998, Brain pathology.

[22]  Y. Ihara,et al.  The car☐yl third of tau is tightly bound to paired helical filaments , 1988, Neuron.

[23]  H. Wiśniewski,et al.  Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. , 1986, The Journal of biological chemistry.

[24]  P. Mcgeer,et al.  Neurofibrillary tangles of Guam parkinson-dementia are associated with reactive microglia and complement proteins , 1996, Brain Research.

[25]  J. Walker,et al.  Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[26]  G. Drewes,et al.  Structure, Microtubule Interactions, and Phosphorylation of Tau Protein a , 1996, Annals of the New York Academy of Sciences.

[27]  M. Kirschner,et al.  Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly. , 1977, Journal of molecular biology.

[28]  S. Feinstein,et al.  Identification of a novel microtubule binding and assembly domain in the developmentally regulated inter-repeat region of tau , 1994, The Journal of cell biology.

[29]  R. Crowther,et al.  Cloning and sequencing of the cDNA encoding an isoform of microtubule‐associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. , 1989, The EMBO journal.

[30]  B T Hyman,et al.  Alz‐50 Antibody recognizes alzheimer‐related neuronal changes , 1988, Annals of neurology.

[31]  A. Delacourte,et al.  Alzheimer??s disease: tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments , 1987 .

[32]  S. Feinstein,et al.  Kinetic stabilization of microtubule dynamics at steady state by tau and microtubule-binding domains of tau. , 1995, Biochemistry.

[33]  D. Dickson,et al.  Heterogeneity of tau proteins in Alzheimer's disease. Evidence for increased expression of an isoform and preferential distribution of a phosphorylated isoform in neurites. , 1993, The American journal of pathology.

[34]  M. Kirschner,et al.  Tau protein binds to microtubules through a flexible array of distributed weak sites , 1991, The Journal of cell biology.

[35]  P. Davies,et al.  Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. , 1992, The Journal of biological chemistry.

[36]  S. Yen,et al.  Structural stability of paired helical filaments requires microtubule-binding domains of Tau: A model for self-association , 1991, Neuron.

[37]  B. Crain,et al.  Interlaboratory Comparison of Neuropathology Assessments in Alzheimer's Disease: A Study of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1994, Journal of neuropathology and experimental neurology.

[38]  S. Mirra,et al.  FILAMENTOUS AGGREGATES IN PICK'S DISEASE, PROGRESSIVE SUPRANUCLEAR PALSY, AND ALZHEIMER'S DISEASE SHARE ANTIGENIC DETERMINANTS WITH MICROTUBULE-ASSOCIATED PROTEIN, TAU , 1986, The Lancet.

[39]  P. Mcgeer,et al.  Association of amyloid P component with complement proteins in neurologically diseased brain tissue , 1991, Brain Research.

[40]  R. Crowther,et al.  Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans , 1996, Nature.

[41]  P. Mcgeer,et al.  Amyloid P immunoreactivity precedes C4d deposition on extracellular neurofibrillary tangles , 1996, Acta Neuropathologica.

[42]  D. Dickson,et al.  A neuronal antigen in the brains of Alzheimer patients. , 1986, Science.

[43]  Masaya Oda,et al.  Glial fibrillary tangles with straight tubules in the brains of patients with progressive supranuclear palsy , 1992, Neuroscience Letters.

[44]  A. Delacourte,et al.  Two‐Dimensional Characterization of Paired Helical Filament‐Tau from Alzheimer's Disease: Demonstration of an Additional 74‐kDa Component and Age‐Related Biochemical Modifications , 1997, Journal of neurochemistry.

[45]  M. Radeke,et al.  Functional interactions between the proline-rich and repeat regions of tau enhance microtubule binding and assembly. , 1997, Molecular biology of the cell.

[46]  E. Mandelkow,et al.  Domains of tau protein and interactions with microtubules. , 1994, Biochemistry.

[47]  M. Tabaton,et al.  Formic acid treatment exposes hidden neurofilament and tau epitopes in abnormal cytoskeletal filaments from patients with progressive supranuclear palsy and Alzheimer's disease , 1990, Neuroscience Letters.

[48]  I Litvan,et al.  Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy) , 1994, Neurology.

[49]  I. Correas,et al.  Differences in microtubule binding and self-association abilities of bovine brain tau isoforms. , 1993, The Journal of biological chemistry.

[50]  D. Davies,et al.  Paired helical filament morphology varies with intracellular location in Alzheimer's disease brain , 1997, Neuroscience Letters.

[51]  H. Wiśniewski,et al.  Neurofibrillary tangles of paired helical filaments , 1976, Journal of the Neurological Sciences.

[52]  A. Delacourte,et al.  Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes , 1998, FEBS letters.

[53]  R. Kalaria,et al.  Widespread serum amyloid P immunoreactivity in cortical amyloid deposits and the neurofibrillary pathology of Alzheimer's disease and other degenerative disorders , 1991, Neuropathology and applied neurobiology.

[54]  D. Dickson,et al.  Alzheimer's neurofibrillary tangles contain unique epitopes and epitopes in common with the heat-stable microtubule associated proteins tau and MAP2. , 1987, The American journal of pathology.